Pharmaguideline provides all pharmaceutical regulatory guidelines including quality control, quality assurance, microbiology, and production departments. Get all SOPs of these all departments. Calibration and operating procedures of all quality control instruments and operating procedures of all production equipment are also provided on the website. All GMP topics are also covered for quality assurance.noreply@blogger.com (Dr. Ankur Choudhary)Thu, 22 Oct 2026 14:43:13 +0530Blogger http://www.blogger.com2385130https://www.pharmaguideline.com/en-usnoPharmaguideline provides all pharmaceutical regulatory guidelines including quality control, quality assurance, microbiology, and production departments. Get all SOPs of these all departments. Calibration and operating procedures of all quality control innoreply@blogger.comhttps://www.pharmaguideline.com/2026/10/cleaning-validation-acceptance-criteria.htmlGMPRegulatoryValidationnoreply@blogger.com (Dr. Ankur Choudhary)Thu, 22 Oct 2026 14:05:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-5966468217558045533Cleaning validation acceptance criteria state the maximum allowed levels of product residues, cleaning agents and other relevant contaminants left on pharmaceutical production equipment after its cleanliness, in order to scientifically justify, quantify and sustain these limits to protect the next product from potential contamination or cross-contamination.The most effective approach is based on 0https://www.pharmaguideline.com/2026/10/validation-data-review.htmlGDPQuality AssuranceValidationnoreply@blogger.com (Dr. Ankur Choudhary)Wed, 21 Oct 2026 13:24:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-6636135774937312258The validation data review is the process of critically analyzing the data generated during validation or qualification studies with the objective of checking whether the study was conducted according to the protocol, whether the data obtained is valid, whether the acceptance criteria were realized and whether the conclusions are based on scientific understanding. In addition to simply 0https://www.pharmaguideline.com/2026/10/dirty-hold-time-study-in-cleaning-validation.htmlGMPQuality AssuranceValidationnoreply@blogger.com (Dr. Ankur Choudhary)Tue, 20 Oct 2026 13:24:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-8396478341960249928A Dirty Hold Time Study during the cleaning validation process calculates the longest period of time manufacturing equipment can stay dirty after the production of a product before the established cleaning process begins. It establishes whether residues will be able to be removed after being subjected to a specified holding condition and if any delays produce any extra chemicals or 0https://www.pharmaguideline.com/2026/10/validation-deviations-classification.htmlGMPQuality AssuranceValidationnoreply@blogger.com (Dr. Ankur Choudhary)Mon, 19 Oct 2026 10:30:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-2765274555595651578A validation deviation is defined as any non-conformance that occurs during any validation or qualification process in relation to the validation protocol that has been previously approved, prescribed acceptance criteria, procedure that has been approved and anticipated conditions. Any validation deviations should be recorded, investigated, classified according to their importance and assessed in0https://www.pharmaguideline.com/2026/10/validation-responsibilities.htmlQuality AssuranceQuality ControlValidationnoreply@blogger.com (Dr. Ankur Choudhary)Sat, 17 Oct 2026 11:00:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-4292838727063500960Validation in the pharmaceutical industry involves multiple departments working together. Quality Assurance (QA), Quality Control (QC), Production and Engineering all add their own knowledge to ensure the validation of processes, instruments, services, tests, etc. The responsibilities for validation must be laid out in the standard operating procedure, description of the validation process and 0https://www.pharmaguideline.com/2026/10/validation-report-review-and-approval.htmlGMPQuality AssuranceValidationnoreply@blogger.com (Dr. Ankur Choudhary)Thu, 15 Oct 2026 17:13:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-4126060578446756793A validation report review is performed to verify if an accomplished validation investigation was executed as per its sanctioned protocol, produced good quality evidence, implemented remediation and satisfied previously set acceptance criteria. Validation report endorsement is the official conclusion that documented data are valid and permissible according to the pharmaceutical quality assurance 0https://www.pharmaguideline.com/2026/10/validation-strategy-in-pharmaceutical.htmlGMPQuality AssuranceValidationnoreply@blogger.com (Dr. Ankur Choudhary)Tue, 13 Oct 2026 14:02:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-2577258929283470242A validation strategy refers to the methodology employed in the pharmaceutical industry to validate that their equipment, processes, utilities and cleaning methods are appropriate for certain purposes and under control during their entire life span. It answers such questions as what will be validated and why, what evidence is required, what guidelines and principles will be followed, 0https://www.pharmaguideline.com/2026/10/types-of-validation-in-pharmaceutical.htmlGMPQuality AssuranceValidationnoreply@blogger.com (Dr. Ankur Choudhary)Sun, 11 Oct 2026 11:26:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-1861047339933010Validation shows that a pharmaceutical process, method, system, facility, or equipment can operate consistently. Validation can mean various things depending on the article that is validated, where it is within its lifecycle, what the company knows about the process, and what its regulatory strategy is. Traditionally, pharmaceutical professionals sum up types of process validation into four 0https://www.pharmaguideline.com/2026/10/validation-sampling-strategy.htmlGMPQuality AssuranceValidationnoreply@blogger.com (Dr. Ankur Choudhary)Fri, 9 Oct 2026 13:43:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-957997705684659071A Validation Sampling Strategy describes what will be sampled, where samples will come from, how many samples will be taken, when sampling will occur and how the data collected will provide evidence of process control. In pharmaceutical validation, sampling is more than a laboratory testing process – it is part of the scientific evidence for the successful completion of a process. Poor sampling 0https://www.pharmaguideline.com/2026/10/validation-periodic-review.htmlGMPRegulatoryValidationnoreply@blogger.com (Dr. Ankur Choudhary)Wed, 7 Oct 2026 12:17:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-8105071985919037760The validation process does not guarantee the continued qualification of pharmaceutical equipment, systems, cleaning methods, or processes. Change in conditions of manufacture, modifications of equipment, occurrences of deviations, emergence of analytical trends and newly acquired process information may all affect the qualification status. Validation Periodic Review is a proper method of 0https://www.pharmaguideline.com/2026/10/validation-effectiveness.htmlGMPQuality AssuranceValidationnoreply@blogger.com (Dr. Ankur Choudhary)Mon, 5 Oct 2026 09:00:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-371511201280507595The efficacy of validation denotes the extent to which an approved process, system, method, equipment, or cleaning practice – that has already been validated – continues to produce intended results on a regular basis. To show that a process is effective within the context of pharmaceutical manufacturing, one needs to have objective proof that the method does produce the required satisfactory 0https://www.pharmaguideline.com/2026/09/common-sterilization-validation-audit-findings.htmlAuditSterilizationValidationnoreply@blogger.com (Dr. Ankur Choudhary)Sat, 3 Oct 2026 15:22:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-6665435308937910555It is expected that sterilization validation will show that a particular sterilization process will be able to ensure the sterility in its intended manner and thus will ensure that the product, its package and container would not be subjected to prohibited influence. Nevertheless, during inspection reviewers rarely limit themselves only to the fact whether the validation procedure has been 0https://www.pharmaguideline.com/2026/09/validation-for-contract-manufacturing.htmlAuditGMPValidationnoreply@blogger.com (Dr. Ankur Choudhary)Thu, 1 Oct 2026 13:12:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-4113052627121182837Carrying out validation in Contract Manufacturing Organizations (CMOs) is more complicated than doing validation in a single-site pharmaceutical company. Product quality is the responsibility of two entities: the contract giver (the entity that owns the marketing authorization or the product) and the contract manufacturer (the entity responsible for production and compliance with GMP).The 0https://www.pharmaguideline.com/2026/09/human-errors-that-affect-process-validation.htmlAuditGMPValidationnoreply@blogger.com (Dr. Ankur Choudhary)Tue, 29 Sep 2026 11:00:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-4601248898287477640Process validation is commonly considered a technical activity involving qualification of instruments, key process characteristics, inspection plans, statistical assessment, etc. However, many defects in the validation processes are caused by much simpler reasons, including human mistakes.A properly designed process may yield erroneous results of the validation due to misunderstanding of 0https://www.pharmaguideline.com/2026/09/common-errors-in-cleaning-validation-reports.htmlCleaning ValidationGMPValidationnoreply@blogger.com (Dr. Ankur Choudhary)Mon, 28 Sep 2026 10:05:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-513517429200760128The cleaning validation report must not stop at declaring equipment cleaned. It must also show a crystal clear, traceable and scientifically validated account of whether the validated cleaning process met its intended purpose.Often, weaknesses in cleaning validation originate not from cleaning itself, but arise in the course of analysis of the final report. Missing raw data, ambiguous acceptance 0https://www.pharmaguideline.com/2026/09/seasonal-hvac-system-qualification.htmlGMPHVACValidationnoreply@blogger.com (Dr. Ankur Choudhary)Sun, 27 Sep 2026 13:48:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-1889287207373438820An HVAC system used in pharmaceuticals might work properly on a normal day, but if the weather conditions become more difficult, it will cause troubles for the HVAC system as well. Both extreme heat and overly low temperatures could influence the pressure within the room, as well as influence temperature stabilization, humidity control, air changes and cleanroom efficiency. This is the reason for0https://www.pharmaguideline.com/2026/09/data-integrity-in-validation.htmlData IntegrityGMPValidationnoreply@blogger.com (Dr. Ankur Choudhary)Sat, 26 Sep 2026 11:50:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-2375627146502041046Validation processes produce some of the key GMP evidence in a pharmaceutical plant. Qualification procedures, performed reports, raw data, calibration documentation, electronic documents, audit trails, calculations, deviations and approvals all together provide information on whether pieces of equipment, systems, procedures or their methods work properly.However, that evidence cannot be 0https://www.pharmaguideline.com/2026/09/managing-validation-deviations-effectively.htmlGMPRegulatoryValidationnoreply@blogger.com (Dr. Ankur Choudhary)Thu, 24 Sep 2026 13:29:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-743692965858515027Validation deviation does not only mean a deviation in the steps of its realization. Refer to such deviations as events that can influence the legitimacy of the conducted study and hence the validity of relevant results and existence of valid state of process, equipment, utility, cleaning operation or analysis method.In order to manage the validation deviations properly, it is necessary to do 0https://www.pharmaguideline.com/2026/09/validation-readiness-for-gmp-regulatory-inspections.htmlGMPRegulatoryValidationnoreply@blogger.com (Dr. Ankur Choudhary)Wed, 23 Sep 2026 10:30:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-4344533357981883015Prior to the regulatory inspection, one of the first documents to be put under scrutiny is the validation document and the teams prepare by reviewing protocols, reports, qualification documents and summaries of validation. While this is necessary, it is not sufficient.It is possible that despite having a complete collection of validation documents, the performance during the inspection may still 0https://www.pharmaguideline.com/2026/09/qualification-of-utilities.htmlEngineeringGMPValidationnoreply@blogger.com (Dr. Ankur Choudhary)Tue, 22 Sep 2026 14:53:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-8260928115146286268While utilities are typically viewed as engineering systems, they can have a direct impact on product quality, contamination control, process performance and batch release in a GMP facility. Qualification of utilities offers the evidence that a utility is designed, installed, operated and shown to function successfully in a given pharmaceutical application.Some examples of utility equipment 0https://www.pharmaguideline.com/2026/09/common-hvac-validation-deviations.htmlEngineeringGMPHVACnoreply@blogger.com (Dr. Ankur Choudhary)Mon, 21 Sep 2026 09:00:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-591031288181325055HVAC qualification has become one of the fields of the pharmaceutical validation protocol that can generate a great number of deviations. Temperature can drift out of acceptance limits, room pressure fails to maintain necessary cascading, airflow can be lower than planned, there can be problems with the HEPA filter integrity, or the smoke study shows there are no desirable airflow patterns.It 0https://www.pharmaguideline.com/2026/09/cleaning-validation-in-ointment-manufacturing.htmlCleaning ValidationOintmentValidationnoreply@blogger.com (Dr. Ankur Choudhary)Sun, 20 Sep 2026 08:30:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-6913078278718853843Cleaning validation in the manufacturing of ointments poses some challenges that differ from those that come with many traditional solid oral dosage forms. Ointments, creams and gels contain waxes, oils, hydrocarbons, fatty materials, emulsifiers, polymers and active ingredients of poor water solubility. Although cleaning may seem visually effective, residues can still remain in places that are 0https://www.pharmaguideline.com/2026/09/sterile-area-classification-gmp-and-iso.htmlGMPRegulatorySterilenoreply@blogger.com (Dr. Ankur Choudhary)Sat, 19 Sep 2026 15:06:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-7110590266807675104The classification of sterile areas indicates how clean the surrounding area must be with regard to the condition of the environment in question in pharmaceutical manufacturing. The concept of sterile area classification also includes regulation of airborne contaminants in sterile processes, where the risk of getting microorganisms is eliminated.On the other hand, pharmaceutical specialists need 0https://www.pharmaguideline.com/2026/09/gmp-compliance-failures.htmlGDPGMPRegulatorynoreply@blogger.com (Dr. Ankur Choudhary)Thu, 17 Sep 2026 12:53:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-6028463798743603978The occurrence of failures in GMP compliance is often linked to a contribution of multiple weak links rather than being a result of a single occurrence of an error or violation in procedures or SOPs. Rather severe GMP compliance problems normally indicate the presence of deficiencies related to pharmaceutical quality system, defects in management supervision, weaknesses with investigation, data 0https://www.pharmaguideline.com/2026/09/critical-quality-attributes-cqas-in pharmaceuticals.htmlGMPQuality AssuranceRegulatorynoreply@blogger.com (Dr. Ankur Choudhary)Tue, 15 Sep 2026 14:34:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-8255708840895712084The term critical quality attributes (CQAs) refers to the objectives established for some of the relevant physical, chemical, biological, or microbiological properties of a drug substance, which must be within appropriate limits or ranges in order for the products to acquire quality. A CQA is not merely any quality test item in a specification. It is critical because it refers to the risk that is0https://www.pharmaguideline.com/2026/09/mock-inspections-in-pharmaceuticals.htmlAuditGMPRegulatorynoreply@blogger.com (Dr. Ankur Choudhary)Sun, 13 Sep 2026 14:03:00 +0530tag:blogger.com,1999:blog-2032508520370173515.post-3747176384699790619It is rare for a regulatory inspection to be problematic because one of the inspectors may ask a surprise question. Problems are usually caused by the fact that the organization does not know how to demonstrate the actual actuality of its operations. While a process may be in compliance, it does not mean that current practices are in line with the procedures. The batch record may be complete, but0https://www.pharmaguideline.com/2026/09/out-of-trend-oot-results-in-quality-control.htmlGDPGLPQuality Controlnoreply@blogger.com (Dr. Ankur Choudhary)Fri, 11 Sep 2026 09:18:15 +0530tag:blogger.com,1999:blog-2032508520370173515.post-4281043128262309456An analytical result does not necessarily have to exceed the specification limit in order to warrant concern regarding product quality. In the pharma industry, a result may be comfortably within the specification limits and yet evidence the occurrence of a change.Such a situation is often referred to as being out of trend (OOT).OOT scenarios are particularly relevant in stability studies, 0https://www.pharmaguideline.com/2026/09/regulatory-actions-in-pharmaceuticals.htmlGMPQuality AssuranceRegulatorynoreply@blogger.com (Dr. Ankur Choudhary)Wed, 9 Sep 2026 12:25:58 +0530tag:blogger.com,1999:blog-2032508520370173515.post-1480589128503356115The occurrence of regulatory action is one of the most severe consequences that can befall a pharmaceutical company as a result of a regulatory agency discovering serious issues with its production, quality, data integrity, or compliance systems.Regulatory actions must not be simply perceived as a punishment. Oftentimes they stem from problems that have persisted over time either without any 0https://www.pharmaguideline.com/2026/09/haccp-in-pharmaceutical-manufacturing.htmlGDPGMPQuality Assurancenoreply@blogger.com (Dr. Ankur Choudhary)Mon, 7 Sep 2026 15:10:38 +0530tag:blogger.com,1999:blog-2032508520370173515.post-3917453918665275010Hazard Analysis and Critical Control Point, commonly known as HACCP, is a systematic preventive technique for identifying hazards and assuring that they are controlled before they threaten product quality. HACCP was developed for food production but the principles can be equally effective when applied in pharmaceutical manufacturing as part of the Pharmaceutical Quality System.In casting the net 0https://www.pharmaguideline.com/2026/09/regulatory-observations-in-pharmaceuticals.htmlGDPGMPRegulatorynoreply@blogger.com (Dr. Ankur Choudhary)Sat, 5 Sep 2026 13:13:38 +0530tag:blogger.com,1999:blog-2032508520370173515.post-6142211173095177182When regulatory authorities make observations, it signals an indication that the company's systems, processes and controls may not comply with regulatory standards. Observations do not imply necessarily that the company's products are flawed or that quality systems have failed in their entirety. Nonetheless, observations reflect concerns raised by the regulatory authorities that necessitate 0